ALMS Alumis Inc.

track record → $22.89 -1.13 (-4.7%)
Get emailed when ALMS changes direction
Mkt Cap $3B 52wk $2.76 - $30.60 Earnings 2026-05-15
Factor Model (net +0.9)

Factor Model

net +0.9
Est. Revisions
+0.4
Insider Activity
+0.5
Momentum
+0.0
Analyst Rev.
+0.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

14h ago Short interest at 17.5% of float, up 9%
17d ago Insider buy by FORESITE LABS, LLC (ALMS): $31,350,000
17d ago Insider buy by FORESITE CAPITAL MANAGEMENT V, LLC. (ALMS): $31,350,000
17d ago Insider buy by TANANBAUM JAMES B (ALMS): $31,350,000
17d ago Insider buy by AKKARAJU SRINIVAS (ALMS): $19,593,750
17d ago Insider buy by BABLER MARTIN (ALMS): $100,733
17d ago Insider buy by COLOWICK ALAN (ALMS): $134,941
17d ago Insider buy by AKKARAJU SRINIVAS (ALMS): $1,477,312
7 older signals
17d ago Insider buy by FORESITE CAPITAL MANAGEMENT VI, LLC. (ALMS): $202,300
17d ago Insider buy by TANANBAUM JAMES B (ALMS): $202,300
17d ago Insider buy by AKKARAJU SRINIVAS (ALMS): $1,449,940
17d ago Insider buy by FORESITE CAPITAL MANAGEMENT VI, LLC. (ALMS): $3,094,725
17d ago Insider buy by TANANBAUM JAMES B (ALMS): $3,094,725
17d ago Insider buy by AKKARAJU SRINIVAS (ALMS): $1,529,865
17d ago Insider buy by AKKARAJU SRINIVAS (ALMS): $905,350
Fundamentals & Data ▾
Alumis Inc. Healthcare · Biotechnology
Mkt Cap
$3B
52w Range
$2.76 - $30.60
Short Interest
12.2M 17.52%
Days to Cover
7.2 +36%
Technicals downtrend
from 52w Hi
-11.9%
1w return
-11.6%
Insiders
buying 12B / 0S
EPS Estimate
$-0.78 +5.6% 30d 1up / 1dn
Est. Dispersion
20% 2 analysts
Analyst Target
$38 $25 - $55
Options P/C
1.39
Insider Cluster
strong buy 7B / 0S (officer)
Fund Convergence
strong Citadel, D.E. Shaw, Renaissance, Two Sigma
Financials
Revenue
$2M
FCF
$-72M
Op Margin
-5000%
Momentum: accelerating
Top Holders
Citadel $2M
D.E. Shaw $2M
Renaissance $1M
Two Sigma
Recent Filings & Data
insider trade 45
net buying · $156,086,100 bought
18 insiders · 45 transactions (30d)
Recent transactions
AKKARAJU SRINIVAS · buy · $9,999,995
TANANBAUM JAMES B · buy · $6,999,988
FORESITE CAPITAL MANAGEMENT VI, LLC. · buy · $6,999,988
AKKARAJU SRINIVAS · buy · $1,833,760
AKKARAJU SRINIVAS · buy · $2,039,901
AKKARAJU SRINIVAS · buy · $1,310,677
TANANBAUM JAMES B · buy · $532,925
FORESITE CAPITAL MANAGEMENT VI, LLC. · buy · $532,925
AKKARAJU SRINIVAS · buy · $905,350
AKKARAJU SRINIVAS · buy · $1,529,865
TANANBAUM JAMES B · buy · $3,094,725
FORESITE CAPITAL MANAGEMENT VI, LLC. · buy · $3,094,725
AKKARAJU SRINIVAS · buy · $1,449,940
HARDIMAN ROY CHARLES · award
SCHROER JOHN R · award
GOLDSTEIN DAVID M PH.D. · award
DRAPPA JORN · award
PANGALI SANAM · award
RICHARDSON DERRICK · award
BRADLEY MARK CHRISTOPHER · award
MACHADO PATRICK · award
AKKARAJU SRINIVAS · award
AYURMAYA CAPITAL MANAGEMENT COMPANY, LP · award
TANANBAUM JAMES B · buy · $202,300
FORESITE CAPITAL MANAGEMENT VI, LLC. · buy · $202,300
AKKARAJU SRINIVAS · buy · $1,477,312
COLOWICK ALAN · buy · $134,941
BABLER MARTIN · buy · $100,733
BABLER MARTIN · award
HARDIMAN ROY CHARLES · award
YAO ZHENGBIN · award
AKKARAJU SRINIVAS · award
AKKARAJU SRINIVAS · other
AKKARAJU SRINIVAS · buy · $19,593,750
GOLDSTEIN DAVID M PH.D. · award
TANANBAUM JAMES B · buy · $31,350,000
TANANBAUM JAMES B · other
FORESITE CAPITAL MANAGEMENT V, LLC. · buy · $31,350,000
FORESITE CAPITAL MANAGEMENT V, LLC. · other
AYURMAYA CAPITAL MANAGEMENT COMPANY, LP · award · $31,350,000
AYURMAYA CAPITAL MANAGEMENT COMPANY, LP · other
FORESITE LABS, LLC · buy · $31,350,000
FORESITE LABS, LLC · other
KLEIN SARA MARION · award
BRADLEY MARK CHRISTOPHER · award
15 signals · latest 14h ago

Get alerted when ALMS changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.